Morgan Stanley’s Gelesis Holdings, Inc. GLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-12,497
Closed -$2.03K 7829
2023
Q1
$2.03K Buy
12,497
+6,354
+103% +$1.82K ﹤0.01% 7232
2022
Q4
$1.78K Sell
6,143
-7,797
-56% -$3.73K ﹤0.01% 7388
2022
Q3
$15K Buy
13,940
+1,967
+16% +$2.6K ﹤0.01% 6938
2022
Q2
$19K Buy
11,973
+8,448
+240% +$34.9K ﹤0.01% 7017
2022
Q1
$16K Buy
+3,525
New +$17.6K ﹤0.01% 7251
2021
Q4
Sell
-5,891
Closed -$58K 8241
2021
Q3
$58K Buy
5,891
+95
+2% +$937 ﹤0.01% 6656
2021
Q2
$57K Sell
5,796
-67
-1% -$659 ﹤0.01% 6618
2021
Q1
$57K Buy
5,863
+5,809
+10,757% +$59.5K ﹤0.01% 6297
2020
Q4
$1K Sell
54
-88
-62% -$866 ﹤0.01% 6992
2020
Q3
$1K Buy
+142
New +$1.4K ﹤0.01% 6694

Other funds holding GLS

Morgan Stanley's GLS Position: Q2 2023 in Review

Morgan Stanley sold out of Gelesis Holdings, Inc. (GLS) in Q2 2023, closing a stake of 12,497 shares — an estimated $2.03K sold.

Morgan Stanley first reported a position in GLS in Q3 2020 and held it in 10 quarters. The position peaked at $58K in Q3 2021. 2 funds tracked by Wall St. Rank hold GLS as of Q2 2023.

  • Morgan Stanley reported no remaining Gelesis Holdings, Inc. position as of Q2 2023 after selling out during the quarter.
  • Morgan Stanley sold 12,497 Gelesis Holdings, Inc. shares in Q2 2023, an estimated $2.03K.
  • Morgan Stanley first reported a position in Gelesis Holdings, Inc. in Q3 2020 and held it in 10 quarters.
  • Morgan Stanley's Gelesis Holdings, Inc. position peaked at $58K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Gelesis Holdings, Inc. as of Q2 2023.

Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.